AngioDynamics to Participate in the Eighth Annual JMP Securities Research ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--May. 14, 2009-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 8^th Annual JMP Securities Research Conference in San Francisco on May 19, 2009, at 11:30 a.m. Pacific Time. Jan Keltjens, President and CEO, and Joseph Gersuk, Executive Vice President and CFO of AngioDynamics, will review the Company’s business strategy and historical financial results.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company’s website at: www.angiodynamics.com. The archived presentation will be available through July 19, 2009.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company’s diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Source: AngioDynamics, Inc.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Jenifer Kirtland, 415-896-6820 (Investor Relations)
jkirtland@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com